(2,23) Use of 2 LABDs (ie, LABA/LAMA) is recommended because complementary mechanisms of action and interactions between pathways maximize bronchodilator response.
Use of ICSs in combination with LABDs is recommended in patients with frequent exacerbations (ie, in group D patients after failure of LAMA/LABA treatment (37)); however, inappropriate use of ICSs in patients with COPD (ie, in groups A-C patients) has been reported.
The dermatologist's differential diagnosis was LABD, followed by bullous erythema multiforme.
The typical clinical presentation of LABD is of small vesicles or bullae, which are annular and may develop into a target shape.
Further investigation is needed to ascertain the association between LABD, vancomycin, and heart disease [5, 7].
One study reported two cases of vancomycin-induced LABD with autoantibodies against BP180 and LAD 285 [5, 9,11].
The LABD closed out Fiscal Year 2011 by setting two new major records.
The 2011 Iowa legislative session made many changes that impact the lABD and liquor licensees.
The COPD patients were categorized into five LABD regimens.
Mean health care costs in the 6-month prestudy period were lowest in the salmeterol group at $12,885 and highest in patients on combination LABD therapy, at nearly $17,100.
Mean health care costs in the 6-month pre-period were lowest in the salmeterol group at $12,885 and highest in patients on combination LABD
therapy, at nearly $17,100.
Dapsone, an immunomodulatory sulfone that has been supported for use in LABD
by case reports and clinical observation, was administered to the patient.